The scope of Biofabrication focuses on the state-of-the-art research and development of biomanufacturing processes, process science, modeling and design. That is, using cells, proteins and biomaterials as building blocks to manufacture biological systems and/or therapeutic products. It includes the following topics:
Descriptions of original scientific research, techniques and applications; not normally more than 12000 words (14 journal pages). All research papers should show strong evidence validating the scientific hypothesis, or the novelty, performance or comparative advantage of the technique or application.
Shorter versions of Papers and not normally more than 4000 words (4 journal pages).
Intended to summarize accepted practice and report on recent progress in selected areas; generally commissioned by the Editorial Board, from experts in various fields.
Comments on, or criticisms of, previously published work or comments on general scientific matters; not normally more than 1800 words (2 journal pages).
Authors of all articles are required upon submission to disclose any potential conflict of interest (e.g. employment, consulting fees, industrial research contracts, stock ownership, equity interests, patent-licensing arrangements, honoraria, etc) in their covering letter. If the article is subsequently accepted for publication, this information should be included in an acknowledgments section. Authors should also note that the journal fully endorses the principles embodied in the Declaration of Helsinki. All investigations involving humans must be conducted in accordance with these principles and in accordance with local statutory requirements. Articles relying on clinical trials should quote the trial registration number at the end of the abstract. We also encourage the registration of such studies in a public trials registry prior to publication of the results in the journal. All investigations involving animal experimentation must be conducted in conformity with the 'Guiding Principles for Research Involving Animals and Human Beings' as adopted by The American Physiological Society.
Sikina Jinnah et al 2009 Environ. Res. Lett. 4 034003
U. Heiter and R. E. Luck 2003 The Astronomical Journal 126 2015
Tadayuki Takahashi et al. 2009 ApJ 697 592
J Winter 2004 Plasma Phys. Control. Fusion 46 B583
D. W. Savin et al. 2006 ApJ 642 1275
Pin-Gao Gu and Takeru K. Suzuki 2009 ApJ 705 1189
Scott F. Anderson et al. 2003 The Astronomical Journal 126 2209
B Schmittmann et al 2005 J. Phys.: Condens. Matter 17 S1817
Y-M Yu et al 2004 J. Phys.: Condens. Matter 16 S5729
A. A. Cowley et al 2009 EPL 85 22001